**Gainers Ranking Observation**



In the past 1 hour, SLP performed the most eye-catching, jumping from $0.001019 to $0.001082, a 6.18% increase. The spot trading volume is particularly active, reaching 8.09 times, but buying pressure is not strong (0.03 times). The futures long-short ratio has reached 1.40, clearly dominated by bulls.

BDXN follows closely, rising 4.28%, with the price increasing from $0.01962 to $0.02046. Although spot data is missing, the futures long-short ratio is 1.55, indicating sufficient bullish strength.

AXS also joins the rally, up 4.26%, with good volume in both spot and futures markets (3.72 times and 2.18 times respectively). ELSA and BARD increased by 4.01% and 3.44%, respectively, especially ELSA's long-short ratio surged to 2.21, showing a clear advantage for the bulls.

**Downside Risks**

Looking at the losers list, CC leads with a 2.68% decline, dropping from $0.1482 to $0.1442. SKL fell 2.59%, which is not significant, but it’s worth noting that—its fee data shows -0.7315%, which usually indicates crowded short positions and potential liquidation risks.

ROSE, SKR, and IRYS are also in a correction phase, with SKR marked as "suspected of a major upcoming move after consecutive listings," possibly building momentum.

**Key Data Summary**

Bullish sentiment: Among the top 5 in the gainers list, SLP, BDXN, AXS, and ELSA all have long-short ratios above 1.30, favoring buyers. Only BARD is different (long-short ratio 0.64), with bears leading.

Trading activity: SLP has the most active volume in the spot market (8.09 times), while ELSA has the most extreme long-short ratio in futures (2.21 times). These are market focal points.

Downside risks: The abnormal fee data and crowded short warning for SKL, along with SKR’s continuous listing phenomenon, are key points for short-term traders to monitor.
SLP-6.62%
BDXN-1.85%
AXS-6.11%
ELSA-3.08%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 6
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned